Dr. Rangaraju is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 6th Ave S
Fl 5
Birmingham, AL 35233Phone+1 205-801-9304
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2020
- University of MinnesotaResidency, Internal Medicine, 2014 - 2017
- Manipal College of Medical ScienceClass of 2012
Certifications & Licensure
- AL State Medical License 2020 - 2024
- IN State Medical License 2017 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 106 citationsAcute lymphoblastic leukemia, version 2.2021Patrick A. Brown, Bijal D. Shah, Anjali S. Advani, Patricia Aoun, Michael Boyer
Journal of the National Comprehensive Cancer Network. 2021-09-01 - 3 citationsHypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia.Omer Jamy, Karen Lin, Sarah Worth, Kimo Bachiashvili, Sravanti Rangaraju
British Journal of Haematology. 2022-08-01 - 5 citationsTumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia.Sankalp Arora, Carl Zainaldin, Srilakshmi Bathini, Udita Gupta, Sarah Worth
Leukemia Research. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: